Evidence map›Paper›PMID 26224629›Full record

ArticleThe Journal of biological chemistry2015

CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.

Yongge Zhao, Chi A Ma, Liming Wu, Kazuhiro Iwai, Jonathan D Ashwell, Eugene M Oltz, Dean W Ballard, Ashish Jain

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. The SUMOylation and ubiquitination crosstalk in cancer.Journal of cancer research and clinical oncology · 2023
    Review
  3. Article
  4. Article
  5. The role of K63-linked polyubiquitination in cardiac hypertrophy.Journal of cellular and molecular medicine · 2018
    Review
  6. All-atom molecular dynamics comparison of disease-associated zinc fingers.Journal of biomolecular structure & dynamics · 2018
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yongge ZhaoFrom the Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892, yongge.zhao@nih.gov.
Chi A MaFrom the Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Liming WuFrom the Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Kazuhiro Iwaithe Department of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
Jonathan D Ashwellthe Laboratory of Immune Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892.
Eugene M Oltzthe Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, and.
Dean W Ballardthe Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee 37232.
Ashish JainFrom the Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892, ashish.jain1@merck.com.
National Institutes of Health · USNational Institute of Allergy and Infectious Diseases · USVanderbilt University · US

Funding

DEREGULATION OF CELLULAR IKB KINASES BY HTLV1 TAXR01CA082556 · NCI · VANDERBILT UNIVERSITY · PI BALLARD, DEAN · 1999 to 2009
$3.6M
Signal-dependent Phosphorylation and Function of IKKyR01AI052379 · NIAID · VANDERBILT UNIVERSITY · PI BALLARD, DEAN · 2003 to 2007
$1.9M
Intramural NIH HHSNCI NIH HHS CA082556NCI NIH HHS R01 CA082556NIAID NIH HHS AI052379NIAID NIH HHS R01 AI052379
6 · The paper itself

Abstract

NF-κB essential modulator (NEMO) and cylindromatosis protein (CYLD) are intracellular proteins that regulate the NF-κB signaling pathway. Although mice with either CYLD deficiency or an alteration in the zinc finger domain of NEMO (K392R) are born healthy, we found that the combination of these two gene defects in double mutant (DM) mice is early embryonic lethal but can be rescued by the absence of TNF receptor 1 (TNFR1). Notably, NEMO was not recruited into the TNFR1 complex of DM cells, and consequently NF-κB induction by TNF was severely impaired and DM cells were sensitized to TNF-induced cell death. Interestingly, the TNF signaling defects can be fully rescued by reconstitution of DM cells with CYLD lacking ubiquitin hydrolase activity but not with CYLD mutated in TNF receptor-associated factor 2 (TRAF2) or NEMO binding sites. Therefore, our data demonstrate an unexpected non-catalytic function for CYLD as an adapter protein between TRAF2 and the NEMO zinc finger that is important for TNF-induced NF-κB signaling during embryogenesis.

Indexed as

Embryonic DevelopmentIntracellular Signaling Peptides and ProteinsReceptors, Tumor Necrosis Factor, Type ITumor Suppressor ProteinsAnimalsApoptosisBlotting, WesternCells, CulturedDeubiquitinating Enzyme CYLDEmbryo, MammalianFibroblastsMice, KnockoutNF-kappa BProtein BindingSignal TransductionTNF Receptor-Associated Factor 2CYLD protein, mouseDeubiquitinating Enzyme CYLDIntracellular Signaling Peptides and ProteinsNEMO protein, mouseNF-kappa BReceptors, Tumor Necrosis Factor, Type ITNF Receptor-Associated Factor 2Tumor Necrosis Factor-alphaTumor Suppressor Proteinscell signalingCYLDimmunodeficiencyNEMONF-κB (NF-KB)protein complextumor necrosis factor (TNF)

Identifiers

PMID26224629
PMCPMC4571959
OpenAlexW1945464499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.